NUE Life Health

Nue Life Health is a mental wellness company founded in 2021 that offers at-home ketamine therapy and virtual aftercare programs. The company provides ketamine treatments via sublingual lozenges, coupled with a companion mobile app and virtual support services. Nue Life's platform combines ketamine therapy with technology-enabled tools like progress tracking, biometric data integration, and curated music playlists designed to enhance the treatment experience.

The company’s main treatment program is Nue Reset, a one-month program with six ketamine experiences. Treatments are administered at home under the guidance of a "sitter" - either in-person or virtually appointed. Nue Life's app allows patients to track their experiences, set wellness goals, and access integration support. The company employs a multidisciplinary team including medical providers, health coaches, and integration specialists to support patients throughout their treatment journey.

Nue Life's approach aims to treat the root causes of mental health issues like depression, anxiety, and PTSD, particularly for treatment-resistant patients. The company claims its combination of ketamine therapy and digital tools can lead to faster relief and more profound healing compared to traditional antidepressants. 

In October 2023, Beckley Waves, a venture studio focused on psychedelic therapies, acquired Nue Life. As of September 2024, Nue Life is operating as an independent company. 

Key customers and partnerships

As of October 2023, Nue Life has successfully provided at-home ketamine therapies, libraries, apps, and aftercare programs to over 10,000 patients throughout the US. The company's services are available in multiple states including Arizona, California, Colorado, Florida, Georgia, Massachusetts, New Jersey, Tennessee, Texas, and Washington, with plans to expand to additional states.

In 2023, Nue Life partnered with Enthea to establish Nue Life as the first at-home ketamine provider in Enthea's network, aiming to increase access to ketamine-assisted therapy services through employer-sponsored health plans.